moa_code	moa_name	target_code	target_site	group_name	chemical_group	common_name	cas_registry	chebi_id	resistance_risk	comment	frac_code
A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	71626-11-4	3009	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	4
						benalaxyl-M (=kiralaxyl)	98243-83-5	82779			
						furalaxyl	57646-30-7	5194			
						metalaxyl	57837-19-1	6790			
						metalaxyl-M (=mefenoxam)	70630-17-0	60607			
					oxazolidinones	oxadixyl	77732-09-3	81937			
					butyrolactones	ofurace	58810-48-3	81969			
		A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	41483-43-6	81952	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	8
						dimethirimol	5221-53-4	81958			
						ethirimol	23947-60-6	81989			
		A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	10004-44-1	5827	unknown	Resistance not known.	32
					isothiazolones	octhilinone	26530-20-1	81936			
		A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	14698-29-4	138856	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	31
B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	17804-35-2	3015	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	1
						carbendazim	10605-21-7	3392			
						fuberidazole	3878-19-1	81926			
						thiabendazole	148-79-8	45979			
					thiophanates	thiophanate	23564-06-9	82060			
						thiophanate-methyl	23564-05-8	35014			
		B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	87130-20-9	4520	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	10
		B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	156052-68-5	82048	low/medium	Low to medium risk. Resistance management required.	22
				thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	162650-77-3	82856			
		B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	66063-05-6	7957	unknown	Resistance not known	20
		B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	239110-15-7	81764	unknown	Resistance not known	43
C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	130339-07-0	82860	unknown	Resistance not known.	39
				pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	129558-76-5	38628			
		C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	15310-01-7	82052	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	7
						flutolanil	66332-96-5	81792			
						mepronil	55814-41-0	81823			
					phenyl-oxo-ethyl thiophene amide	isofetamid	875915-78-9	83065			
					pyridinyl-ethyl-benzamides	fluopyram	658066-35-4	83070			
					furan- carboxamides	fenfuram	24691-80-3	81994			
					oxathiin- carboxamides	carboxin	5234-68-4	3405			
						oxycarboxin	5259-88-1	7858			
					thiazole- carboxamides	thifluzamide	130000-40-7	81794			
					pyrazole-4- carboxamides	benzovindiflupyr	1072957-71-1	83092			
						bixafen	581809-46-3	83106			
						fluxapyroxad	907204-31-3	83113			
						furametpyr	123572-88-3	81793			
						isopyrazam	881685-58-1	83126			
						penflufen	494793-67-8	83134			
						penthiopyrad	183675-82-3	81777			
						sedaxane	874967-67-6	83173			
					pyridine- carboxamides	boscalid	188425-85-6	81822			
		C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	131860-33-8	40909	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	11
						coumoxystrobin	850881-70-8	83185			
						enoxastrobin	238410-11-2	83187			
						flufenoxystrobin	918162-02-4	83194			
						picoxystrobin	117428-22-5	83197			
						pyraoxystrobin	862588-11-2	83202			
					methoxy-acetamide	mandestrobin	173662-97-0	83205			
					methoxy-carbamates	pyraclostrobin	175013-18-0	78780			
						pyrametostrobin	915410-70-7	83212			
						triclopyricarb	902760-40-1	83213			
					oximino-acetates	kresoxim-methyl	143390-89-0	2962			
						trifloxystrobin	141517-21-7	81833			
					oximino-acetamides	dimoxystrobin	149961-52-4	83218			
						fenaminstrobin	366815-39-6	83220			
						metominostrobin	133408-50-1	81831			
						orysastrobin	248593-16-0	81832			
					oxazolidine-diones	famoxadone	131807-57-3	59340			
					dihydro-dioxazines	fluoxastrobin	361377-29-9	83253			
					Imidazolinones	fenamidone	161326-34-7	83258			
					benzyl-carbamates	pyribencarb	799247-52-2	83261			
		C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	120116-88-3	81841	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	21
					sulfamoyl-triazole	amisulbrom	348635-87-0	81846			
		C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	485-31-4	82153	unknown	Resistance not known. Also acaricidal activity.	29
						meptyldinocap	131-72-6	83372			
						dinocap	39300-45-3	83379			
					2,6-dinitro-anilines	fluazinam	79622-59-6	81843	low	Low risk. However, resistance claimed in Botrytis in Japan.	
					(pyr.-hydrazones)	(ferimzone)	89269-64-7	81844		Reclassified to U 14 in 2012.	
		C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	900-95-8	81918	low/medium	Some resistance cases known. Low to medium risk.	30
						fentin chloride	639-58-7	35036			
						fentin hydroxide	76-87-9	30473			
		C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	175217-20-6	83393	low	Resistance reported. Risk low.	38
		C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	865318-97-4	83398	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	45
D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	121552-61-2	4045	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	9
						mepanipyrim	110235-47-7	6751			
						pyrimethanil	53112-28-0	8674			
		D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	2079-00-7	15353	low/medium	Low to medium risk. Resistance management required.	23
		D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	6980-18-3	81419	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	24
		D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	57-92-1	17076	high	Bactericide. Resistance known. High risk. Resistance management required.	25
		D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	79-57-2	27701	high	Bactericide. Resistance known. High risk. Resistance management required.	41
E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	124495-18-7	82040	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	13
					quinazolinone	proquinazid	189278-12-4	83555			
		E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	74738-17-3	34759	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	12
						fludioxonil	131341-86-1	81763			
		E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	84332-86-5	3656	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	2
						iprodione	36734-19-7	28909			
						procymidone	32809-16-8	8450			
						vinclozolin	50471-44-8	9986			
F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a				n/a	n/a	NA
		F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	17109-49-8	34735	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	6
						iprobenfos (IBP)	26087-47-8	79737			
						pyrazophos	13457-18-6	81942			
				dithiolanes	dithiolanes	isoprothiolane	50512-35-1	6047			
		F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	92-52-4	17097	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	14
						chloroneb	2675-77-6	3628			
						dicloran	99-30-9	27864			
						quintozene (PCNB)	82-68-8	34908			
						tecnazene (TCNB)	117-18-0	82044			
						tolclofos-methyl	57018-04-9	81731			
				heteroaromatics	1,2,4-thiadiazoles	etridiazole	2593-15-9	81761			
		F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	55406-53-6	83279	low/medium	Low to medium risk. Resistance management required.	28
						propamocarb	24579-73-5	82033			
						prothiocarb	19622-08-3	82084			
		F5	none	formerly CAA-fungicides	n/a				n/a	n/a	NA
		F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713			unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	44
						Bacillus amyloliquefaciens strain FZB24					
						Bacillus amyloliquefaciens strain MBI600					
						Bacillus amyloliquefaciens strain D747					
		F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)		83629	unknown	Resistance not known	46
G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	26644-46-2	9715	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	3
					pyridines	pyrifenox	88283-41-4	81972			
						pyrisoxazole	847749-37-5	83823			
					pyrimidines	fenarimol	60168-88-9	4998			
						nuarimol	63284-71-9	7645			
					imidazoles	imazalil	35554-44-0	81927			
						oxpoconazole	134074-64-9	83832			
						pefurazoate	101903-30-4	81775			
						prochloraz	67747-09-5	8434			
						triflumizole	68694-11-1	81784			
					triazoles	azaconazole	60207-31-0	81898			
						bitertanol	55179-31-2	3130			
						bromuconazole	116255-48-2	81900			
						cyproconazole	94361-06-5	81758			
						difenoconazole	119446-68-3	81760			
						diniconazole	83657-18-5	81913			
						epoxiconazole	133855-98-8	4811			
						etaconazole	60207-93-4	4874			
						fenbuconazole	114369-43-6	81762			
						fluquinconazole	136426-54-5	83923			
						flusilazole	85509-19-9	81922			
						flutriafol	76674-21-0	81923			
						hexaconazole	79983-71-4	81766			
						imibenconazole	86598-92-7	81767			
						ipconazole	125225-28-7	81770			
						metconazole	125116-23-6	81773			
						myclobutanil	88671-89-0	75281			
						penconazole	66246-88-6	81970			
						propiconazole	60207-90-1	8489			
						simeconazole	149508-90-7	81819			
						tebuconazole	107534-96-3	81781			
						tetraconazole	112281-77-3	81782			
						triadimefon	43121-43-3	9665			
						triadimenol	55219-65-3	9666			
						triticonazole	131983-72-7	81980			
					triazolinthiones	prothioconazole	178928-70-6	82036			
		G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	91315-15-0	83295	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	5
						dodemorph	1593-77-7	81960			
						fenpropimorph	67564-91-4	50145			
						tridemorph	81412-43-3	9700			
					piperidines	fenpropidin	67306-00-7	81917			
						piperalin	3478-94-2	83283			
					spiroketal-amines	spiroxamine	118134-30-8	9242			
		G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	126833-17-8	81853	low/medium	Low to medium risk. Resistance management required.	17
					amino-pyrazolinone	fenpyrazamine	473798-59-3	83327			
		G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	88678-67-5	81736	unknown	Resistance not known, fungicidal and herbicidal activity	18
					allylamines	naftifine	65472-88-0	7451	unknown	Medical fungicides only	
						terbinafine	91161-71-6	9448			
H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	37248-47-8	29703	unknown	Resistance not known	26
		H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	11113-80-7	26194	medium	Resistance known. Medium risk. Resistance management required.	19
		H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	110488-70-5	81848	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	40
						flumorph	211867-47-9	83428			
						pyrimorph	868390-90-3	83663			
					valinamide carbamates	benthiavalicarb	413615-35-7	83601			
						iprovalicarb	140923-17-7	82023			
						valifenalate	283159-90-0	83610			
					mandelic acid amides	mandipropamid	374726-62-2	81802			
I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	27355-22-2	47617	unknown	Resistance not known	16.1
					pyrrolo-quinolinone	pyroquilon	57369-32-1	45141			
					triazolobenzo-thiazole	tricyclazole	41814-78-2	81783			
		I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	104030-54-8	3434	medium	Resistance known. Medium risk. Resistance management required.	16.2
					carboxamide	diclocymet	139920-32-4	3434			
					propionamide	fenoxanil	115852-48-7	3434			
P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	135158-54-2	3434	unknown	Resistance not known	P1
		P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	27605-76-1	3434	unknown	Resistance not known 	P2
		P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	223580-51-6	81825	unknown	Resistance not known	P3
						isotianil	224049-04-1	83657			
		P4	none	natural compound	polysaccharides	laminarin	9008-22-4	6364	unknown	Resistance not known	P4
		P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)		6364	unknown	Resistance not known	P5
U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	57966-95-7	81788	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	27
		U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	39148-24-8	84033	low	Few resistance cases reported in few pathogens. Low risk	33
					phosphorous acid and salts	phosphorous acid and salts	13598-36-2	44976			
		U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	76280-91-6	83341	unknown	Resistance not known	34
		U4	unknown	benzotriazines	benzotriazines	triazoxide	72459-58-6	83335	unknown	Resistance not known	35
		U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	106917-52-6	81801	unknown	Resistance not known	36
		U6	unknown	pyridazinones	pyridazinones	diclomezine	62865-36-5	81759	unknown	Resistance not known	37
		U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	66952-49-6	81933	unknown	Resistance not known	42
		U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	180409-60-3	81797	unknown	Resistance in Sphaerotheca. Resistance management required	U6
		U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	220899-03-6	83345	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	U8
					benzoylpyridine	pyriofenone	688046-61-9	83346			
		F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	2439-10-3	74889	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	U12
		U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	958647-10-4	83277	unknown	Resistance not known	U13
		U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	89269-64-7	81844	unknown	Resistance not known. Reclassified from C5 in 2012.	U14
		U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	1003318-67-9	83268	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	U15
		U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	376645-78-2	83266	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	U16
N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin			unknown	Resistance not known	NC
M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	7440-50-8		low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	M1
				inorganic	inorganic	sulphur	7704-34-9	17909			M2
				dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	14484-64-1	5015			M3
						mancozeb	8018-01-7	52492			
						maneb	12427-38-2	52497			
						metiram	9006-42-2	81539			
						propineb	12071-83-9	81755			
						thiram	137-26-8	9495			
						zineb	12122-67-7	52498			
						ziram	137-30-4	79736			
				phthalimides	phthalimides	captan	133-06-2	34608			M4
						captafol	2425-06-1	81938			
						folpet	133-07-3	82019			
				chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	1897-45-6	3639			M5
				sulfamides	sulfamides	dichlofluanid	1085-98-9	74875			M6
						tolylfluanid	731-27-1	75182			
				guanidines	guanidines	guazatine	108173-90-6	82843			M7
						iminoctadine	13516-27-3	5569			
				triazines	triazines	anilazine	101-05-3	82076			M8
				quinones (anthraquinones)	quinones (anthraquinones)	dithianon	3347-22-6	81842			M9
				quinoxalines	quinoxalines	chinomethionat / quinomethionate	2439-01-2	34620			M10
				maleimide	maleimide	fluoroimide	41205-21-4	81826			M11
